Eagle Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-59,931
| Closed | -$2.89M | – | 568 |
|
|
2020
Q2 | $2.89M | Sell |
59,931
-957,556
| -94% | -$46.1M | 0.02% | 419 |
|
|
2020
Q1 | $43M | Buy |
1,017,487
+12,081
| +1% | +$510K | 0.27% | 143 |
|
|
2019
Q4 | $43M | Sell |
1,005,406
-5,257
| -0.5% | -$225K | 0.21% | 183 |
|
|
2019
Q3 | $36.4M | Buy |
1,010,663
+10,545
| +1% | +$380K | 0.19% | 181 |
|
|
2019
Q2 | $26.7M | Buy |
+1,000,118
| New | +$26.7M | 0.14% | 216 |
|
|
2016
Q4 | – | Sell |
-979,303
| Closed | -$31.2M | – | 629 |
|
|
2016
Q3 | $31.2M | Buy |
979,303
+24,276
| +3% | +$772K | 0.21% | 150 |
|
|
2016
Q2 | $31M | Sell |
955,027
-76,346
| -7% | -$2.48M | 0.21% | 144 |
|
|
2016
Q1 | $28.8M | Buy |
1,031,373
+369,857
| +56% | +$10.3M | 0.2% | 158 |
|
|
2015
Q4 | $23.6M | Buy |
661,516
+45,162
| +7% | +$1.61M | 0.16% | 192 |
|
|
2015
Q3 | $20.4M | Buy |
+616,354
| New | +$20.4M | 0.14% | 210 |
|